Association of polymorphism in the transcription factor LBP-1c/CP2/LSF gene with Alzheimer's disease and major depression

Dementia and Geriatric Cognitive Disorders

Volumn 22, Issue 1, 2006, Pages 95-98

  Schahab, Schamim ^a   Heun, Reinhard ^a   Schmitz, Sandra ^a   Maier, Wolfgang ^a   Kölsch, Heike ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Alzheimer's disease; Chromosome 12; LBP 1c polymorphism; Major depression

Indexed keywords

APOLIPOPROTEIN E4; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; SOMATOMEDIN B RECEPTOR; TRANSCRIPTION FACTOR;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 12; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DNA POLYMORPHISM; FEMALE; GENE LOCATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; TRANSCRIPTION INITIATION;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHROMOSOMES, HUMAN, PAIR 12; DEPRESSIVE DISORDER, MAJOR; DNA; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; HUMANS; LOGISTIC MODELS; MALE; POLYMORPHISM, GENETIC; RECEPTOR, IGF TYPE 2; RECEPTORS, LDL; RISK; TRANSCRIPTION FACTORS;

EID: 33745202867     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093460     Document Type: Article

References (24)

1. Rosenberg RN: The molecular and genetic basis of AD: the end of the beginning. Neurology 2000;54:2045-2054.
2. Lambert JC , Goumidi L, Wavrant-De Vrieze F, et al: The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Molec Genet 2000;9:2275-2280.
3. Taylor AE, Yip A, Brayne C, et al: Genetic association of an LBP-1c/CP2/LSF gene polymorphism with late onset Alzheimer's disease. J Med Genet 2001;38:232-233.
4. Pericak-Vance MA, Bass MP, Yamaoka LH, et al: Complete genomic screen in late-onset familial Alzheimer's disease: evidence for a new locus on chromosome 12. JAMA 1997;278:1237-1241.
5. Blacker D, Wilcox MA, Laird NM, et al: Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998;19:357-360.
6. Lendon CL, Talbot CJ, Craddock N, et al: Genetic association studies with the receptors for apolipoprotein E and Alzheimer's disease. Neurosci Lett 1997;222:187-190.
7. Schellenberg GD, D'Souza I, Poorkaj P: The genetic of Alzheimer's disease. Curr Psych Rep 2000;2:158-164.
8. Mayeux R, Lee JH, Romas SN, et al: Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am J Genet 2000;70:237-243.
9. Myers A, De-Vierze FW, Holmans P, et al: Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 2002;114:235-244.
10. Lendon C, Craddock N: Is LBP-1c/CP2/LSF a disease-modifying gene for Alzheimer's disease? Lancet 2001;358:1029-1030.
11. Zambrano N, Minopoli G, de Candia P, Russo T: The Fe65 adaptor protein interacts through its PIDI domain with transcription factor CP2/LSF/LBP1. J Biol Chem 1998;273:20128-20133.
12. Lau KF, Miller CC, Anderton BH, Shaw PC: Molecular cloning and characterization of the human glycogen synthase kinase-3 beta promoter. Genomics 1999;60:121-128.
13. Luedecking-Zimmer E, DeKosky ST, Nebes R, Kamboh MI: Association of 3′UTR transcription factor LBP-1c/CP2/LSF polymorphism with late-onset Alzheimer's disease. Am J Med Genet 2003;117B:114-117.
14. Panza F, D'Introno A, Colacicco AM, et al: LBP-1c/CP2/LSF gene polymorphism and risk of sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:166-168.
15. Modrego PJ, Ferrandez J: Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 2004;61:1290-1293.
16. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state', a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Hamajima N: PCR-CTPP: a new genotyping technique in the era of genetic epidemiology. Expert Rev Mol Diagn 2001;1:119-123.
18. Hatanaka Y, Kamino K, Fukuo K, et al: Low destiny lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Azheimer's disease in Japanese population. Clin Genet 2000;58:319-323.
19. Hixson JF, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-548.
20. Kim HS, Kim EM, Lee JP, et al: C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J 2003;17:1951-1953.
21. Kosuga S, Tashiro E, Kajioka T, Ueki M, Shimizu Y, Imoto M: GSK-3beta directly phosphorylates and activates MARK2/PAR-1. J Biol Chem 2005;280:42715-42722.
22. Gould TD, Einat H, Bhat R, Manji HK: ARA014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 2004;7:387-390.
23. Kölsch H, Ptok U, Majores M, Schmitz S, Rao ML, Maier W, Heun R: Putative association of polymorphism in the mannose 6-phosphate receptor gene with major depression and Alzheimer's disease. Psychatr Genet 2004;14:97-100.
24. Toyota T, Watanabe A, Shibuya H, et al: Association study on the DUSP6 gene, an affective disorder candidate gene on 12q23, performed by using fluorescence resonance energy transfer-based melting curve analysis on the LightCycler. Mol Psychiatry 2000;5:489-494.